Liver Cancer Stage 2 Doctors Abroad — Page 3

Associate Professor Tahsin Ozatli is a specialist oncologist at Istinye University Liv Hospital, with deep expertise in managing gastrointestinal and liver-related cancers.

• Specialises in systemic therapy for liver and gastrointestinal tumours
• Former physician at the Ankara Oncology Clinic – one of Turkey's major cancer centres
• Achieved official rank of Associate Professor in 2016 for his clinical contributions
• Practised at Erzurum Regional Training and Research Hospital – a key clinical hub

Associate Professor Yusuf Acikgoz brings high-level expertise to liver cancer care, having recently completed a medical oncology residency at the Ohio State University.

• Serves as an Assistant Investigator for international phase III clinical trials on immunotherapy.
• Holds membership in the American Society of Clinical Oncology (ASCO).
• Certified in Good Clinical Practice to provide rigorous, evidence-based treatment protocols.
• Completed specialist immuno-oncology training through the Central European Cooperative Oncology Group in Vienna.

Professor Ozden is a dual-specialist in internal medicine and oncology at VM Medical Park Pendik, focusing on targeted systemic treatments.

• Trained at Istanbul University Cerrahpaşa Faculty of Medicine – one of Turkey's most prestigious medical schools
• Specialises in medical oncology, managing chemotherapy and immunotherapy protocols for abdominal tumours
• Focuses on precision medicine to target cancer cells while sparing healthy tissue
• Member of the Turkish Society of Medical Oncology

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Associate Professor Nail Paksoy is a board-certified medical oncologist whose expertise in gastrointestinal cancers is backed by international clinical trial experience and ESMO certification.

• Specialises in systemic therapies for liver and gastrointestinal cancers
• Served as a subinvestigator for major international clinical trials with Bayer and Roche
• Holds European Society for Medical Oncology (ESMO) board certification
• Published extensive research on targeted therapies and treatment outcomes
• Associate Professor at Medipol University, a leading Turkish medical institution

Associate Professor Babek Tabandeh is a senior surgeon at Medical Park Göztepe and a member of the American College of Surgeons. He specialises in cancer surgery and minimally invasive techniques for complex cases.

• Member of the Liver Transplantation Society, focusing on surgical liver care
• Performs minimally invasive surgery using small incisions for faster patient recovery
• Teaches the next generation of doctors at Bahçeşehir University Faculty of Medicine
• Published over 40 research documents on surgical techniques and outcomes
• Member of the Turkish Medical Association and Istanbul Surgery Association

Professor Muzaffer Al treats advanced oncological cancer cases at Büyük Anadolu Hospitals – he completed intensive training in abdominal cancer surgery at Istanbul University Cerrahpaşa.

• Specialises in laparoscopic cancer surgery to remove tumours with smaller incisions and less pain
• Trained in oncological cancer surgery at one of Turkey's top medical faculties
• Uses minimally invasive techniques for complex procedures to help speed up recovery
• Refined his abdominal surgery skills through specialised laparoscopic training at Istanbul University

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.